INTRODUCTION
Among the chelating agents that have found applications in medicine, DTPAH 5 (diethylenetriaminepentaacetic acid) remains one of the most commonly used (14) because it forms stable complexes with many cations (12) and allows the preparation of bifunctional chelating derivatives, which can easily be linked to high molecular weight compounds. [[ 111 In](DTPA)] 2Ϫ has been described as an ideal agent for scintigraphic studies of the cerebrospinal fluid pathway (10, 14) . DTPAH 5 is also the ligand of choice in one of the widely used magnetic resonance imaging (MRI) contrast agents [Gd(III)(DTPA)] 2Ϫ (Magnevist: Berlex; Wayne, NJ, USA) (31) . One of the important characteristics of this ligand is that it allows functionalization via the carboxylic functional groups simply by using the DTPA-bisanhydride as a precursor (15, 23) . The DTPA amide derivatives (either bisamides or monoamide) possess the same number of donor atoms (three nitrogens and five oxygens) as DTPAH 5 , with a reduction of ionizable groups. These acyclic ligands have some advantages relative to macrocyclic analogues in biomedical applications because of their much higher complexation rates and their higher flexibility in coordinating cations compared to the macrocyclic compounds, although their generally faster dissociation kinetics and lower thermodynamic stability can constitute serious disadvantages (27) .
DTPAH 5 is an octadentate ligand that can bind to a metal ion through five deprotonated carboxylate groups and the three tertiary amino groups (21) . In the past, we had prepared a series of new DTPA mono and bis-amides ( Fig. 1) by derivatizing one or two of the DTPAH 5 carboxylate groups to amide functionalities with a variety of substituents (2, 8 (10, 11) , relevant for the assessment of the potential applications of the DTPA amide chelates in nuclear medicine. The ligands (L 1 to L 13 ) form a series of neutral or negatively charged complexes with In 3ϩ with varying molecular properties, in particular, with a different lipophilic/hydrophilic character. An increased hydrophobicity may lead to stronger interactions of these chelates, for example, with proteins such as human serum albumin (HSA) or lipophilic entities, potentially altering their biodistribution. The factors determining biliary versus urinary excretion are chiefly influenced by three main chelate properties: polarity, molecular size and weight, and structure (4, 5, 18, 19) . Here we also assess the correlation of the observed in vitro and in vivo behavior of these 111 In 3ϩ complexes with those molecular properties, contributing to the design of new and more specific radiopharmaceuticals.
MATERIALS AND METHODS

Reagents and Apparatus
[ 111 In]Cl 3 was obtained from CIS-Biointernational (Sarclay, France); instant thin layer chromatography-silica gel (ITLC-SG) was from Gelman Sciences, Inc. (Ann Arbor, MI, USA); HSA (crystallized and lyophilized) was from Sigma (Madrid, Spain). All the ligands used in this work were synthesized and characterized as described elsewhere (1, 2, 8, 9, 16 ). Other reagents and solvents were obtained from either Aldrich or Sigma and were used as received. All reagents for in vivo use were prepared sterile and pyrogen-free. A gamma camera-computer system (GE 400 GenieAcq, General Electric, Milwaukee, WI, USA) was used for acquisition and preprocessing. Data processing and display were performed on a personal computer using homemade software developed for the IDL 5.2 computer tool. A ␥ well-counter (DPCGamma C 12 ) with a Compaq DeskPro compatible computer was used for activity counting in the biodistribution studies.
Determination of 1-Octanol/Saline Partition Coefficients
111
In 3ϩ complexes were prepared in distilled water by mixing the ligand with [
111 In]Cl 3 (in a 10:1 ratio) and adjusting the pH to approximately 7 with 0.1 M NaOH. The partition coefficients were determined by addition of 25 L of 111 In 3ϩ -chelate solution in a test tube containing 1 mL of saline solution and 1 mL of 1-octanol. The tubes were vortexed and centrifuged for 3 min at 3,000 rpm. Then, aliquots of 100 L of each phase were taken for radioactivity counting. The partition coefficients were calculated by dividing the net radioactivity counting of the organic phase by that of the aqueous phase. The results presented are the means of five determinations (with an SD of Ͻ0.01).
Calculation of 1-Octanol/Water Partition Coefficients
The 1-octanol/water partition coefficients for the free ligands (L 1 to L 10 ) were calculated using the log KOW program from SRC (Syracuse Research Corporation, New York, NY, USA) using a SMILE (Simplified Molecular Input Line Entry System) notation to represent each molecule. The calculations were based upon the additive-constitutive character of the partition coefficient (P) and the use of a substituent constant x , which is defined as Eq. (1) (7, 20) :
where P x is the partition coefficient of the derivative of a parent molecule with a partition coefficient P H .
Interaction of Human Serum Albumin with 111 In
3؉
Chelates
Albumin solutions were freshly prepared by dissolving HSA in HEPES 0.1 M buffer to obtain 0.6 mM concentration (assuming 69 KDa as the HSA molecular weight). 0.2-mM L 9 and L 10 water solutions were labeled with a small amount of [
111 In]Cl 3 (in 0.1 N HCl), and afterwards InCl 3 (nonradioactive indium chloride) was added to obtain a 1:1 complex. These solutions were mixed with 2 mL of the HSA solution and were continuously stirred for 6 h and then left overnight at room temperature. A 1 mL sample was then dialyzed for 24 h, through membranes retaining molecules above 12 KDa at 281 K (30) . Aliquots were collected inside and outside the membrane and counted in a ␥ well-counter. Total protein binding of InL chelates was calculated as percent of the applied InL solution that was retained inside the membrane (30).
Gamma Imaging
Stock solutions of the ligands were prepared in isotonic HEPES 0.1 M buffer and mixed with [
111 In]Cl 3 (0.1 N HCl) to obtain 1:1 111 In 3ϩ complexes (with 10% ligand excess). The efficiency of labeling of the ligands with 111 In 3ϩ was checked by chromatography (an ITLC-SG/butanone system), indicating that an approximately 100% radiochemically pure preparation of the complex was achieved. Gamma images and biological distributions for the 111 In 3ϩ complexes were determined using 300 g Wistar rats. All animal studies were carried out in compliance with procedures approved by the appropriate institutional review committees. Conscious rats were allowed free access of food and water ad libitum. Groups of four animals (one group for each complex) were anaesthetized with Ketamine (50 mg/mL)/chloropromazine (2.5%) (10:3) and injected in the tail vein with approximately 150 Ci of the respective 111 In 3ϩ chelate. The animals were then positioned in dorsal decubitus over the detector. Image acquisition was initiated immediately before radiotracer injection. Sequences of 180 images (of 10 s each), were acquired to 64 ϫ 64 matrices. Blood samples were taken during the dynamic acquisition (at 5, 15, and 30 min) and subsequently counted in a ␥ well-counter. The clearance of radiotracer over time was followed by time-activity curves on images obtained from three regions of interest, thorax, liver, and left kidney. In addition, static data were acquired at 24, 48, and 72 h after the radiotracer injection.
Biodistribution Studies
Groups of four animals were injected with approximately 100 Ci of the complexes and sacrificed 2 h later. The major organs (liver, spleen, left kidney, heart, lung, intestines, brain) were removed, weighed, and counted in a ␥ well-counter.
RESULTS AND DISCUSSION
Partition Coefficients
The binding of a wide variety of nonionic organic compounds of miscellaneous structures to both bovine serum albumin (BSA) and bovine hemoglobin appears to depend almost exclusively on hydrophobic interactions and is linearly related to their octanol-water partition coefficient (13) . The partitioning between octanol and water has been used to predict the ability of a compound to be absorbed and to distribute out of the vascular compartment into (9) . A more recent relaxivity study with the Gd 3ϩ complexes of some of the presently studied ligands, GdL i (i ϭ 1, 2, 5, 7, 9) (2), has suggested that the bisamide derivatives with greater hydrophobic character may originate stronger interactions with HSA, but the protein binding sites did not recognize aryl or norbonyl side chains, as well as short substituent groups. The only quantitative binding study for this series was for GdL 9 , with an association constant K A ϭ (5.7 Ϯ 1.3) ϫ 10 3 M Ϫ1 , giving a value of 72% for the bound fraction of GdL 9 (0.1 mM) in the presence of 0.6 mM HSA. Thus, the 80% HSA-bound fraction for InL 9 measured in the same conditions in the present study is comparable to that of GdL 9 . Figure 3 shows the averaged time-activity curves obtained from dynamic acquisitions up to 30 min for two regions of interest (left kidney and liver) using some representative complexes. The mean thorax activity/pixel was considered as the background activity. The values of mean activity/pixel for each region of interest (RI), after background deduction, were used to obtain regional time/activity curves. The curves were normalized relative to the maximum activity obtained for each complex. We can clearly divide the chelates studied into two main groups according to their clearance pathway. For the more hydrophilic 111 In 3ϩ chelates (with the ligands, L 3 , L 4 , and L 11 -L 13 ), the kidney activity/time curves, obtained from the dynamic acquisitions, generally show two different portions: an initial sharper one corresponding to uptake and a slower second one corresponding to slower clearance. This type of profile, exemplified in Figure 3 (Fig. 3) when compared with the neutral hydrophilic complexes due to its negative charge. Instead, we can notice from Fig. 3 that these chelates have a very similar renal behavior. Some of these hydrophilic complexes show a small amount of activity at the liver-spleen region, which can be related with colloidal particles of indium hydroxide trapped by the reticuloendothelial system. However, the high thermodynamic stability of this type of complexes [e.g., log K (InL 4 ) ϭ 20.4] (8) (1.5% after 24 h) (26) , indicating that conditional stability (defined as stability of the chelates at physiological conditions) is more important than thermodynamic stability to rationalize in vivo (Fig. 3 ), L 9 ( Fig. 3) , and L 10 , a pronounced uptake in the first few seconds was followed by a period of slow elimination of the radiotracer. This behavior suggests the implication of the liver in the metabolism of these complexes. Figure 4 shows the scintigraphic images of rats at 30 min after the injection of [
In Vivo Studies
Gamma Imaging
111 In]L 6 and
For the more lipophilic complexes, almost all the radioactivity was at the intestines, corresponding to the excretory phase of the chelates. However, a small activity in the bladder is also observed for most of these chelates, indicating that renal clearance is also present.
In the images obtained at 24 and 48 h after injection of all the 111 In 3ϩ complexes (data not shown), a residual activity in the liver-spleen region was observed, possibly due to decomplexation and precipitation of indium hydroxides. As the complexes are thermodynamically quite stable (8) kinetic instability, which should influence their in vivo behavior (27) .
Biodistribution Studies
The results of animal biodistribution studies at 2 h (in percent of injected dose per gram of organ or tissue) for the chelates studied are summarized in Table 2 10 . This fact indicates that liver uptake is not only a function of lipophilicity. Conversely, other less obvious parameters govern the amount of radioactivity clearing through the liver as it has been pointed out by other previous studies with 67 Ga 3ϩ and 111 In 3ϩ chelates (3, 22, 23, 24) . We found no evidence of bone uptake, which would reflect uptake in the bone marrow that is seen when the In 3ϩ -transferrin complex is formed (28, 29) . Thus, this is evidence that the chelates remained intact for the time they stayed in blood. This agrees with thermodynamic stability constants and pM values reported elsewhere for some of these bis-amides chelates, which were found to be higher than that determined for the In 3ϩ -transferrin complex (8), the main competitor for In 3ϩ and Ga 3ϩ in blood (28, 29) . None of the complexes passed through the blood-brain barrier, as expected for high molecular weight and/or low lipophilic complexes. In fact, several authors have estimated the molecular weight cut-off for brain extraction to be between 400 and 600 for substances with log P Ͼ 2 (6, 18).
CONCLUSION
In this work, we have used a large series of bisamide ligands (and one monoamide), previously synthesized, based on the structure of DTPAH 5 , and have shown that simple substitutions in this ligand can cause major alterations in the biodistribution and clearance of their 111 In 3ϩ chelates. While the more hydrophilic complexes clear by the kidneys, the more lipophilic chelates clear by the liver and gastrointestinal tract, thus demonstrating the influence of lipophilicity in the clearance of these 111 In 3ϩ chelates. However, within this later group, the observed liver uptake is much more pronounced than what would be expected based on their experimental log P values. This clearly illustrates that liver uptake is not just a simple function of lipophilicity, but other, less obvious parameters govern the amount of radioactivity clearing through the liver (3, 22, 23, 24) . On other hand, the complex charge does not seem to be very relevant in their in vivo behavior, at least in what concerns low negative-charged complexes. The blood retention of the chelates also correlates better with their binding to HSA than with their hydrophilic/lipophilic ratio.
The results of the present systematic structure-biodistribution study may contribute to the optimization of the properties of the potential radiopharmaceuticals derived from the 111 In 3ϩ chelates of DTPA. 
